TG Therapeutics (TGTX) Competitors $32.22 -0.24 (-0.75%) As of 02:07 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock TGTX vs. SMMT, GMAB, ASND, VTRS, RDY, QGEN, BBIO, MRNA, VRNA, and ELANShould you be buying TG Therapeutics stock or one of its competitors? The main competitors of TG Therapeutics include Summit Therapeutics (SMMT), Genmab A/S (GMAB), Ascendis Pharma A/S (ASND), Viatris (VTRS), Dr. Reddy's Laboratories (RDY), QIAGEN (QGEN), BridgeBio Pharma (BBIO), Moderna (MRNA), Verona Pharma PLC American Depositary Share (VRNA), and Elanco Animal Health (ELAN). These companies are all part of the "pharmaceutical products" industry. TG Therapeutics vs. Its Competitors Summit Therapeutics Genmab A/S Ascendis Pharma A/S Viatris Dr. Reddy's Laboratories QIAGEN BridgeBio Pharma Moderna Verona Pharma PLC American Depositary Share Elanco Animal Health Summit Therapeutics (NASDAQ:SMMT) and TG Therapeutics (NASDAQ:TGTX) are both medical companies, but which is the superior business? We will compare the two businesses based on the strength of their dividends, earnings, institutional ownership, risk, media sentiment, valuation, profitability and analyst recommendations. Does the media refer more to SMMT or TGTX? In the previous week, Summit Therapeutics had 21 more articles in the media than TG Therapeutics. MarketBeat recorded 28 mentions for Summit Therapeutics and 7 mentions for TG Therapeutics. TG Therapeutics' average media sentiment score of 1.11 beat Summit Therapeutics' score of 0.86 indicating that TG Therapeutics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Summit Therapeutics 8 Very Positive mention(s) 4 Positive mention(s) 7 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive TG Therapeutics 3 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, SMMT or TGTX? Summit Therapeutics has a beta of -1.02, indicating that its stock price is 202% less volatile than the S&P 500. Comparatively, TG Therapeutics has a beta of 1.88, indicating that its stock price is 88% more volatile than the S&P 500. Do insiders and institutionals hold more shares of SMMT or TGTX? 4.6% of Summit Therapeutics shares are owned by institutional investors. Comparatively, 58.6% of TG Therapeutics shares are owned by institutional investors. 84.9% of Summit Therapeutics shares are owned by company insiders. Comparatively, 10.6% of TG Therapeutics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Do analysts prefer SMMT or TGTX? Summit Therapeutics currently has a consensus price target of $33.79, suggesting a potential upside of 78.86%. TG Therapeutics has a consensus price target of $46.25, suggesting a potential upside of 43.56%. Given Summit Therapeutics' higher probable upside, equities analysts clearly believe Summit Therapeutics is more favorable than TG Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Summit Therapeutics 3 Sell rating(s) 1 Hold rating(s) 12 Buy rating(s) 1 Strong Buy rating(s) 2.65TG Therapeutics 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Is SMMT or TGTX more profitable? TG Therapeutics has a net margin of 13.31% compared to Summit Therapeutics' net margin of 0.00%. TG Therapeutics' return on equity of 26.05% beat Summit Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Summit TherapeuticsN/A -208.64% -181.28% TG Therapeutics 13.31%26.05%9.58% Which has preferable earnings and valuation, SMMT or TGTX? TG Therapeutics has higher revenue and earnings than Summit Therapeutics. Summit Therapeutics is trading at a lower price-to-earnings ratio than TG Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioSummit TherapeuticsN/AN/A-$221.32M-$1.01-18.70TG Therapeutics$329M15.54$23.38M$0.3787.07 SummaryTG Therapeutics beats Summit Therapeutics on 11 of the 16 factors compared between the two stocks. Get TG Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for TGTX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TGTX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TGTX vs. The Competition Export to ExcelMetricTG TherapeuticsMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$5.11B$3.15B$5.81B$10.17BDividend YieldN/A2.32%5.69%4.61%P/E Ratio87.0721.3774.6226.02Price / Sales15.54294.32466.0690.52Price / Cash265.2945.3337.0859.91Price / Book22.539.6212.166.30Net Income$23.38M-$53.29M$3.29B$270.86M7 Day Performance0.02%0.35%1.07%3.41%1 Month Performance18.79%8.99%7.38%6.56%1 Year Performance38.93%12.97%63.13%28.27% TG Therapeutics Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TGTXTG Therapeutics4.1683 of 5 stars$32.22-0.7%$46.25+43.6%+40.7%$5.11B$329M87.07290Positive NewsSMMTSummit Therapeutics3.0813 of 5 stars$19.44-25.2%$33.79+73.8%-18.1%$19.30BN/A-19.25110Insider TradeGap UpHigh Trading VolumeGMABGenmab A/S3.96 of 5 stars$27.54flat$37.60+36.5%+6.2%$17.67B$3.12B16.102,682News CoveragePositive NewsASNDAscendis Pharma A/S3.1082 of 5 stars$205.22-0.3%$244.36+19.1%+75.0%$12.60B$393.54M-39.771,017Positive NewsVTRSViatris1.6727 of 5 stars$10.48-0.2%$10.40-0.8%-10.3%$12.24B$14.74B-3.6132,000Positive NewsRDYDr. Reddy's Laboratories2.484 of 5 stars$14.27-0.5%$16.95+18.8%-7.1%$11.97B$3.81B21.6127,811Positive NewsQGENQIAGEN4.468 of 5 stars$47.62+0.1%$49.69+4.4%+3.3%$10.57B$1.98B28.135,765Positive NewsBBIOBridgeBio Pharma4.4486 of 5 stars$54.29+1.7%$63.35+16.7%+87.9%$10.20B$221.90M0.00400Positive NewsAnalyst ForecastMRNAModerna4.5036 of 5 stars$24.83-1.2%$42.88+72.7%-68.1%$9.78B$3.24B0.005,800Positive NewsVRNAVerona Pharma PLC American Depositary Share2.1761 of 5 stars$106.300.0%$109.00+2.5%+252.9%$9.20B$42.28M-107.3730Positive NewsELANElanco Animal Health2.6335 of 5 stars$19.02+3.2%$17.33-8.9%+29.8%$9.16B$4.44B22.129,000Positive News Related Companies and Tools Related Companies Summit Therapeutics Alternatives Genmab A/S Alternatives Ascendis Pharma A/S Alternatives Viatris Alternatives Dr. Reddy's Laboratories Alternatives QIAGEN Alternatives BridgeBio Pharma Alternatives Moderna Alternatives Verona Pharma PLC American Depositary Share Alternatives Elanco Animal Health Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TGTX) was last updated on 9/12/2025 by MarketBeat.com Staff From Our PartnersStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredUrgent: $3,452.50 a Month in Passive "AI Equity Checks"The U.S. government just took advantage of Public Law 81-774 to crack down on AI companies... In turn, enfo...Angel Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredTrump’s Plan May Undo 1933’s Biggest Financial InjusticeTrump's Reset Can Give Birth To America's Greatest Era Yet A 90-Year cycle may end soon, creating real weal...American Hartford Gold | SponsoredGENIUS Act: The Plot to Seize Your Cash?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | SponsoredBuffett, Gates and Bezos Quietly Dumping Stocks—Here's WhyImagine a bull market so powerful, every single investor became a millionaire. Not by finding the next NVIDIA ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding TG Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share TG Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TGTX Stock Alerts